Esperion Therapeutics
ESPR
#7692
Rank
โ‚น23.60 B
Marketcap
โ‚น119.32
Share price
-3.13%
Change (1 day)
-48.70%
Change (1 year)

Earnings for Esperion Therapeutics (ESPR)

Earnings in 2024 (TTM): โ‚น0.61 Billion

According to Esperion Therapeutics's latest financial reports the company's current earnings are โ‚น0.33 Billion. , an increase over its 2023 earnings that were of -โ‚น12.86 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Esperion Therapeutics from 2000 to 2024

Annual earnings

Year Earnings Change
2024 โ‚น0.64 B-104.99%
2023 -โ‚น12.86 Billion-15.03%
2022 -โ‚น15.13 Billion-20.61%
2021 -โ‚น19.06 Billion84.28%
2020 -โ‚น10.34 Billion35.75%
2019 -โ‚น7.62 Billion-55.71%
2018 -โ‚น17.2 Billion19.57%
2017 -โ‚น14.39 Billion125.39%
2016 -โ‚น6.39 Billion51.43%
2015 -โ‚น4.22 Billion36.45%
2014 -โ‚น3.09 Billion43.55%
2013 -โ‚น2.16 Billion145.26%
2012 -โ‚น0.88 Billion
2002 -โ‚น2.51 Billion-7.81%
2001 -โ‚น2.72 Billion15.03%
2000 -โ‚น2.36 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚น43.16 Billion-6,821.89%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น46.33 B 7,117.73%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น950.52 B 147,954.89%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น408.83 B 63,581.06%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น2.46 Billion-483.11%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น17.15 Billion-2,769.90%๐Ÿ‡บ๐Ÿ‡ธ USA